Samuel Martel

[Matteo Lambertini, MD PhD @matteolambe]

Finally #ASCO18 time, meeting friends before full working days! @SamuelMartel87 @noam_ponde @E_de_Azambuja @M_Preusser @Philippe_Bedard @marciomed1

[Matteo Lambertini, MD PhD @matteolambe]

First author of the @asco guidelines @ndenduluri1 reviewing the data on #HER2-positive early #BreastCancer at #ASCO18

[Matteo Lambertini, MD PhD @matteolambe]

Congrats @Frafrap1987 for this achievement and clear data: addition of a #platinum agent to standard #neoadjuvant #chemotherapy increases #pCR rates by 20% but no benefit for #BRCA patients (that have already high pCR rates with standard CT) #ASCO18

[Gil Morgan, MD @weoncologists]

Happy knowing both top #oncology societies,which I am a member of @ASCO & @myESMO care about #Oncology #fellows .Remember: @Annals_Oncology paper on #burnout . If a fellow, read it,if senior recognize it.Take care of your fellows,they will take care of you https://t.co/gT5nG9hDhM

[Harold J. Burstein, MD, PhD, FASCO @DrHBurstein]

Meta-analysis of ovarian suppression during chemo to preserve fertility.
Amenorrhea at 2 years: 18% with GnRH agonist, vs 30% without
More pregnancies in GnRH group. No pregnancies after age 40.
No impact on DFS or OS.
Thus, GnRH protection is safe and preserves fertility.

[Matteo Lambertini, MD PhD @matteolambe]

Meta-analysis by @SamuelMartel87 et al. on risk of #AdverseEvents in patients with ER–positive #AdvancedBreastCancer featured by @ASCOPost #ABClisbon @ELS_Oncology
https://t.co/S6vjrLgAYP via @ascopost

[Matteo Lambertini, MD PhD @matteolambe]

Congrats from the fellows to @aftimosp for his new position as head of the CTCU at @JulesBordet

[European Cancer Organisation @EuropeanCancer]

Plan your application for the #MCCRworkshop: https://t.co/Dl2tEG8zUd #ClinicalTrialDesign #cancerresearch @AACR @EORTC @myESMO

[Matteo Lambertini, MD PhD @matteolambe]

No association of #BMI with clinical outcomes in #HER2+ #AdvancedBreastCancer @SamuelMartel87 @puglisi_fabio
https://t.co/QIZJ5WjPuq

[Emma Mason 💙 @wordEmason]

Englewood Health News story on #ABCLisbon poster here: https://t.co/8YtACBvCEk https://t.co/bhoITtOkOw

[Matteo Lambertini, MD PhD @matteolambe]

Adverse events with targeted agents + endocrine therapy in luminal #AdvancedBreastCancer
#ABClisbon @ELS_Oncology
https://t.co/YUjWIwSxVm

[Mason, Rice & Noble @RiceMason]

Report on @MatteoLambe ABCLisbon presentation: https://t.co/lcD3gFjNPw

[Matteo Lambertini, MD PhD @matteolambe]

Italian leading experts in #BreastCancer presenting at #ABClisbon on very challenging topics
#ABC4 @curijoey @ESOncology

[Matteo Lambertini, MD PhD @matteolambe]

#Fertility preservation strategies are feasible also in #BRCA mutated #BreastCancer patients @Annals_Oncology
https://t.co/zqBTjj8RFB

[Christian Maurer @Maurer_Oncology]

#DontForgetStage4 #ABClisbon @ESOncology

[Samuel Martel @SamuelMartel87]

@matteolambe @JulesBordet The year passed too fast in such good company at @JulesBordet
Thank you all for your support and friendship